Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Christopher T. Salerno"'
Autor:
Ezequiel J. Molina, Jennifer Cowger, Sangjin Lee, Douglas Horstmanshof, Joseph C. Cleveland, Daniel J. Goldstein, Mandeep R. Mehra, Nir Uriel, Christopher T. Salerno, Kevin Bourque, Joyce Chuang, Yoshifumi Naka
Publikováno v:
The Annals of thoracic surgery. 114(6)
Outcomes in patients with smaller body size after HeartMate 3 left ventricular assist device (HM3) implantation are not well characterized. We sought to evaluate outcomes in smaller vs larger body surface area (BSA) patients in the MOMENTUM 3 pivotal
Autor:
Christopher T. Salerno, Christopher Hayward, Shelley Hall, Daniel Goldstein, Diyar Saeed, Jan Schmitto, David Kaczorowski, Ezequiel Molina, Daniel Zimpfer, Steven Tsui, Edward Soltesz, Duc Thin Pham, Nahush A. Mokadam, Arman Kilic, Erin Davis, Erika Feller, Angela Lorts, Scott Silvestry, Mark S. Slaughter, Evgenij Potapov, Pavan Atluri, Jennifer Cowger, Francis D. Pagani
Publikováno v:
The Annals of thoracic surgery. 113(6)
The HeartWare HVAD System (Medtronic) is a durable implantable left ventricular assist device that has been implanted in approximately 20,000 patients worldwide for bridge to transplant and destination therapy indications. In December 2020, Medtronic
Autor:
Sagar Ranka, Travis Abicht, Zubair Shah, Ioannis Mastoris, Aniket S Rali, Giorgio Zanotti, Moghni Mohammed, Farhad Sami, Christopher T. Salerno, A. Ravichandran, Savahanna Wagner, Andrew J. Sauer, Prakash Acharya, Nicholas Haglund
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 16, Iss 1, Pp 1-1 (2021)
Journal of Cardiothoracic Surgery
Journal of Cardiothoracic Surgery
Left ventricular assist devices (LVAD) have been increasingly used in the treatment of end-stage heart failure. While warfarin has been uniformly recommended in the long-term as anticoagulation strategy, no clear recommendation exists for the post-op
Publikováno v:
JACC: Case Reports, Vol 2, Iss 9, Pp 1365-1367 (2020)
JACC: Case Reports
JACC: Case Reports
Shared decision making with patients in advanced heart failure is critical when making decisions on therapies such as left ventricular assist device implantation and cardiac transplantation. We describe a case wherein the risks of coronavirus disease
Autor:
Mandeep R, Mehra, Nir, Uriel, Yoshifumi, Naka, Joseph C, Cleveland, Melana, Yuzefpolskaya, Christopher T, Salerno, Mary N, Walsh, Carmelo A, Milano, Chetan B, Patel, Steven W, Hutchins, John, Ransom, Gregory A, Ewald, Akinobu, Itoh, Nirav Y, Raval, Scott C, Silvestry, Rebecca, Cogswell, Ranjit, John, Arvind, Bhimaraj, Brian A, Bruckner, Brian D, Lowes, John Y, Um, Valluvan, Jeevanandam, Gabriel, Sayer, Abeel A, Mangi, Ezequiel J, Molina, Farooq, Sheikh, Keith, Aaronson, Francis D, Pagani, William G, Cotts, Antone J, Tatooles, Ashok, Babu, Don, Chomsky, Jason N, Katz, Paul B, Tessmann, David, Dean, Arun, Krishnamoorthy, Joyce, Chuang, Ia, Topuria, Poornima, Sood, Daniel J, Goldstein, Ahmet, Kilic
Publikováno v:
New England Journal of Medicine. 380:1618-1627
In two interim analyses of this trial, patients with advanced heart failure who were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device were less likely to have pump thrombosis or nondisabling stroke than were
Autor:
Francis D. Pagani, Jennifer A Cowger, Christopher T. Salerno, Keith D. Aaronson, Shannon M. Dunlay, Todd F. Dardas, Palak Shah, Ashwin Ravichandran, Ramesh Singh, Nahush A. Mokadam, John M. Stulak
Publikováno v:
ASAIO Journal. 64:721-726
Highly specialized left ventricular assist device care is not readily available in many areas, potentially limiting access to therapy. This retrospective analysis examines the relationship of outcomes by patient distance from implanting left ventricu
Autor:
Sean Pinney, Vinay Thohan, Poornima Sood, Melana Yuzefpolskaya, Scott C. Silvestry, Carmelo A. Milano, Daniel J. Goldstein, Akinobu Itoh, Joseph C. Cleveland, Mandeep R. Mehra, Nir Uriel, Scott Goates, Christopher T. Salerno, Joyce Chuang, Sanjeev K. Gulati, Francis D. Pagani, Ranjit John, Roberta C. Bogaev, Robert M. Adamson
Publikováno v:
Circulation. 138:1923-1934
Background: The MOMENTUM 3 trial compares the centrifugal HeartMate 3 (HM3) with the axial HeartMate II (HMII) continuous-flow left ventricular assist system in patients with advanced heart failure, irrespective of the intended goal of therapy. The t
Autor:
Christopher T. Salerno, Aniket S Rali, Ioannis Mastoris, Nicholas Haglund, Moghni Mohammed, Farhad Sami, Savahanna Wagner, Andrew J. Sauer, A. Ravichandran, Prakash Acharya, Giorgio Zanotti, Sagar Ranka, Travis Abicht, Zubair Shah
Publikováno v:
Journal of Cardiothoracic Surgery
Journal of Cardiothoracic Surgery, Vol 15, Iss 1, Pp 1-8 (2020)
Journal of Cardiothoracic Surgery, Vol 15, Iss 1, Pp 1-8 (2020)
Background Left ventricular assist devices (LVAD) have been increasingly used in the treatment of end-stage heart failure. While warfarin has been uniformly recommended in the long-term as anticoagulation strategy, no clear recommendation exists for
Autor:
Sunit-Preet Chaudhry, Shannon Tompkins, Mary Norine Walsh, James P. Adlam, K.L. Morris, Caitlin Hoefer, M. Padanilam, Erica Seasor, Giorgio Zanotti, A. Patel, R. Garcia-Cortes, Christopher T. Salerno, A. Ravichandran, Markian Bochan
Publikováno v:
Clinical transplantationREFERENCES. 34(1)
Introduction Patients with end-stage heart failure eligible for orthotopic heart transplantation (OHT) exceed the number of available donor organs. With highly effective hepatitis C virus (HCV) antiviral therapy now available, HCV+ organs are increas
Autor:
John B. O'Connell, Nirav Raval, G. Bhat, Akinobu Itoh, Christopher T. Salerno, Rebecca Cogswell, Lahn Fendelander, David A. Dean, Eric Skipper, Francis D. Pagani, Yoshifumi Naka, Mandeep R. Mehra, Nir Uriel, Carmelo A. Milano, Brian A. Bruckner, Joseph C. Cleveland, Jerry D. Estep, Daniel J. Goldstein
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:7-14
Background Primary outcomes analysis of the Multicenter Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 (MOMENTUM 3) trial short-term cohort demonstrated a higher survival rate free of debilitating stroke and reoperatio